LEADER 05406nam 2200697 450 001 9910132337203321 005 20230803203258.0 010 $a1-118-58917-3 010 $a1-118-58919-X 010 $a1-118-58916-5 035 $a(CKB)3710000000134370 035 $a(EBL)1780034 035 $a(SSID)ssj0001261108 035 $a(PQKBManifestationID)11715811 035 $a(PQKBTitleCode)TC0001261108 035 $a(PQKBWorkID)11326988 035 $a(PQKB)10925068 035 $a(OCoLC)890441754 035 $a(MiAaPQ)EBC1780034 035 $a(DLC) 2014009510 035 $a(Au-PeEL)EBL1780034 035 $a(CaPaEBR)ebr10928099 035 $a(CaONFJC)MIL642303 035 $a(EXLCZ)993710000000134370 100 $a20140916h20142014 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCancer consult $eexpertise for clinical practice /$fedited by Syed A. Abutalib, Maurie Markman 210 1$aHoboken, New Jersey :$cWiley-Blackwell,$d2014. 210 4$dİ2014 215 $a1 online resource (987 p.) 300 $aDescription based upon print version of record. 311 $a1-322-11052-2 311 $a1-118-58921-1 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Dedication; Title page; Copyright page; Contents; List of Contributors; Preface; SECTION 1: Malignant Hematology and Hematopoietic Cell Transplantation; PART 1: Acute Lymphoblastic Leukemia in Adults; CHAPTER 1: Diagnosis of acute lymphoblastic leukemia; Selected readings; Case study answers; CHAPTER 2: Prognostic markers and models in acute lymphoblastic leukemia; Pretherapeutic prognostic markers; Age; White blood cell count; Cytogenetic and genetic markers; Immunophenotype; Pro-B-ALL/t(4; 11); Common and pre-B-ALL; T-lineage ALL; Response parameters 327 $aStratification into risk groups Selected reading; CHAPTER 3: Management of B-cell acute lymphoblastic leukemia; Selected reading; CHAPTER 4: Management of T-cell acute lymphoblastic leukemia; Selected reading; CHAPTER 5: Minimal residual disease in acute lymphoblastic leukemia; Case study answers; Selected reading; CHAPTER 6: Hematopoietic cell transplantation in adult acute lymphoblastic leukemia; Multiple choice and discussion questions; Selected reading; Multiple choice answer; Case study answer; PART 2: Acute Myeloid Leukemia in Adults 327 $aCHAPTER 7: Prognosis in acute myeloid leukemia: cytogenetics and beyond Selected reading; Case study answers; CHAPTER 8: Induction therapy in acute myeloid leukemia; Selected reading; Case study answers; CHAPTER 9: Consolidation therapy in acute myeloid leukemia; Selected reading; CHAPTER 10: Management of acute promyelocytic leukemia; Selected reading; CHAPTER 11: Minimal residual disease in acute myeloid leukemia; Selected reading; CHAPTER 12: Relapsed and refractory acute myeloid leukemia; Multiple choice questions; Selected reading; Case study answers; Mutiple choise answers 327 $aCHAPTER 13: Hematopoietic cell transplantation in acute myeloid leukemia Multiple choice question; Case study answers; Multiple choice answer; Selected reading; PART 3: Myelodysplastic Syndromes and Related Disorders; CHAPTER 14: Pitfalls in the diagnosis of myelodysplastic syndromes; Selected reading; Case study answers; CHAPTER 15: Cytogenetics and prognostic models in myelodysplastic syndromes; MDS cytogenetics and prognosis; Conclusion; Selected reading; CHAPTER 16: Management of myelodysplastic syndromes; Selected reading; CHAPTER 17: Management of therapy-related myeloid neoplasms 327 $aIntroduction Multiple choice questions; What is the most appropriate treatment for the following patients?; Selected reading; Multiple choice answers; CHAPTER 18: Hematopoietic cell transplantation in myelodysplastic syndromes; Selected reading; CHAPTER 19: Acquired aplastic anemia; Selected reading; Case study answers; PART 4: Myeloproliferative Neoplasms; CHAPTER 20: Diagnostic approach in myeloproliferative neoplasms; Introduction; Selected reading; CHAPTER 21: Chronic myeloid leukemia: chronic phase; Introduction; Multiple choice and discussion questions; Selected reading 327 $aMultiple choice answer 330 $aThe field of oncology benefits from several large-scale reference books and a host of monographs dedicated to specific cancers. However, truly excellent practice and review books are, surprisingly, quite scarce. Outside of a scant handful of books and online reference tools that offer clinical response practice and board review in a basic question and answer format, there are no resources that offer a robust, engaging, fully referenced tool for these vital activities in every oncologist's and oncology trainee's work. This print and electronic book seeks to fill that void, offering comprehensive 606 $aCancer 606 $aStem cells$xTransplantation 606 $aOncology 615 0$aCancer. 615 0$aStem cells$xTransplantation. 615 0$aOncology. 676 $a616.99/40076 702 $aAbutalib$b Syed A. 702 $aMarkman$b Maurie 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910132337203321 996 $aCancer consult$92232067 997 $aUNINA